2024 In Focus: Predictions From Florence's Top Leaders On Clinical Research Collaboration

Navigating the landscape of clinical research collaboration in 2024 requires a nuanced understanding of evolving dynamics among sites, sponsors, and CROs. In an insightful interview, Florence's leadership—Ryan Jones, CEO; Catherine Gregor, Chief Clinical Trial Officer; Kristin Surdam, Sr. Director, KOL & Strategy; and Mike Wenger, VP of Solutions—delve into the transformative impact of technology on collaboration.

From shaping current dynamics to their expectations for upcoming technological investments, the leaders shed light on crucial industry trends. They candidly discuss barriers they aim to overcome in the coming year, offering a pragmatic perspective on the challenges that lie ahead. This interview not only provides a glimpse into the forward-looking strategies of industry leaders but also serves as a valuable resource for professionals navigating the complex terrain of clinical research collaboration in the evolving landscape of 2024.